Healthy subject
Conditions
Interventions
Low dose soy peptide containing powder 10g, 2 weeks
Middle dose soy peptide containing powder 10g, 2 weeks
Dextrin containing powder (Placebo) 10g, 2 weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)More than 60 years and less than 70 years old. 2)Right-handed healthy Japanese.
Exclusion criteria
Exclusion criteria: 1)Patient with Alzhheimer's desease 2)Patient with food, drug, and/or specifically soy allergy 3)Patient who had treatment, hospitalization, and/or surgery due to Stroke, Subarachnoid hemorrhage, Cerebral infarction, Cerebral hemorrhage, Brain contusion, and/or Head trauma 4)Patient who ingested in excessive alcohol 5)Patient with chronic or acute infection 6)Patient who has current disease or history of hepatitis 7)Patient with dementia 8)Patient who are attending a hospital by following diseases or has medical history of Attack, Seizures, Diabetes, Thyroid dysfunction, Blood dialysis, Uremia, Anuria, Inner ear disease (Meniere's disease and so on), and/or Asthma 9)Patient with medical history of serious disorder (Liver disease, Kidney disease, Hypertension, Ischemic heart disease, Impaired glucose tolerance and so on) 10)Patient who has received the neuropsychological tests in hospital 11)Patient with movement disorders, visual impairment, hearing impairment 12)Patient who has experience to feel sick by watching shiny light 13)Patient on a diet 14)Patient with excessive smoking habit 15)Patient who has habitual intake of pharmaceuticals and foods (general food, dietary supplement, functional food, health food, food for health claims, beverage, confectionary and so on) which may affect test results 16)Patient participating in other clinical trials at the start of the present study 17)Patient who the investigator deems inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of correct answers on neuropsychological tests Subjective mood states | — |
Secondary
| Measure | Time frame |
|---|---|
| Salivary parameter | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness support Co., Ltd. Clinical trial Division
Outcome results
None listed